Concepedia

Talal Ben Lulu

TB

Statistics

Publications

3

Citations

89

H-Index

3

Active since

2023

Affiliations

Tianjin Medical University(Current)

Ben-Gurion University of the Negev

Tianjin Institute of Pharmaceutical Research (China)

Talal Ben Lulu is an author at Tianjin Medical University specializing in molecular oncology, oncology, and medicine.

Publications per year

2023–2024

3

Publications

3

Activation of the <scp>EGFR</scp> / <scp>PI3K</scp> / <scp>AKT</scp> pathway limits the efficacy of trametinib treatment in head and neck cancer

Ofra Novoplansky, Avital Beeri Shnerb, Divyasree Marripati et al. · Molecular Oncology · 2023 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation

Xin Peng, Xin Huang, Talal Ben Lulu et al. · Molecular Cancer · 2024 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer

Sankar Jagadeeshan, Manu Prasad, Mai Badarni et al. · Cancer Research · 2023 · 24 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–3 of 3